Do intracranial (brain) aneurysms have a genetic basis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, Brain Aneurysms Have a Significant Genetic Component

Brain aneurysms are transmitted genetically, with familial occurrence ranging from 7-20% of cases, and first-degree relatives having a 1.9- to 5.9-fold increased risk of developing intracranial aneurysms 1.

Genetic Evidence and Inheritance Patterns

The genetic basis of intracranial aneurysms (IAs) is well-established through multiple lines of evidence:

Autosomal dominant transmission is suspected to be the most common mode of inheritance, though the exact patterns remain incompletely understood 1. Multiple genetic loci have been identified through genome-wide association studies, with the strongest evidence pointing to:

  • Chromosome 9 (CDKN2B antisense inhibitor gene)
  • Chromosome 8 near SOX17 gene
  • Chromosome 4 near EDNRA gene
  • Additional regions on chromosomes 1p34.3-p36.13, 7q11, 19q13.3, and Xp22 1

Recent large-scale genetic studies have identified 17 risk loci and confirmed substantial genetic contribution to sporadic IAs 2, 3.

Family History Risk Quantification

The risk for family members is substantial and well-documented:

  • First-degree relatives have 4% (95% CI: 2.6%-5.8%) prevalence of unruptured aneurysms on MRA screening 1
  • Siblings have higher risk than children of affected individuals 1
  • In the Familial Intracranial Aneurysm Study, 19.1% of screened first-degree relatives (>30 years old with smoking or hypertension) had at least one aneurysm 1
  • Risk increases dramatically when ≥2 family members are affected 1

In long-term screening studies of families with ≥2 affected first-degree relatives, aneurysms were detected in:

  • 11% at first screening
  • 8% at second screening
  • 5% at third and fourth screenings over 10 years 1

This demonstrates persistent risk even after initial negative screenings.

Associated Genetic Syndromes

Certain genetic conditions carry substantially elevated risk (3- to 14-fold for some conditions) 1:

  • Autosomal dominant polycystic kidney disease (highest risk: 3-14 fold increase)
  • Type IV Ehlers-Danlos syndrome
  • Marfan syndrome
  • Coarctation of the aorta
  • Neurofibromatosis type 1
  • Fibromuscular dysplasia

However, these syndromic cases constitute <10% of all patients presenting with unruptured aneurysms, meaning the majority result from polygenic inheritance combined with environmental factors 1.

Gene-Environment Interactions

The genetic risk is amplified by modifiable factors, particularly:

  • Smoking (most significant modifiable risk)
  • Hypertension
  • Female sex
  • Older age
  • Higher lipid levels
  • Higher fasting glucose 1

Recent genome-wide studies demonstrate that genetic risks for smoking and high blood pressure drive most of the genetic correlation between intracranial aneurysms and other cerebrovascular traits 2.

Clinical Implications

No obvious Mendelian inheritance pattern exists for most familial aneurysms, indicating complex polygenic inheritance 4. The disease shows high genetic correlation between ruptured and unruptured aneurysms, suggesting shared genetic architecture 2.

The polygenic nature means that while family history significantly increases risk, most individuals with affected relatives will not develop aneurysms, and conversely, most aneurysm patients have no family history. The genetic contribution explains over half of disease heritability 2, with the remainder attributable to environmental and lifestyle factors.

Important caveat: Despite advances in genetic understanding, there is currently no reliable genetic diagnostic test to identify high-risk individuals beyond family history assessment and screening imaging 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.